Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis

NCT01235442 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

592

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: 1=Etanercept
DRUG: 2=Clobetasol propionate foam

Sponsor

Amgen

Collaborators

[object Object]